Financial data analysis helps to double-check if markets are presently mispricing Apex Biotechnology Corp. We are able to interpolate and break down thirty-eight available fundamental indicators for Apex Biotechnology Corp, which can be compared to its peers. The stock experiences a normal downward trend and little activity. Check odds of Apex Biotechnology to be traded at NT$30.59 in 90 days.
Apex
Understanding current and past Apex Biotechnology Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Apex Biotechnology's financial statements are interrelated, with each one affecting the others. For example, an increase in Apex Biotechnology's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Apex Biotechnology's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Apex Biotechnology Corp. Check Apex Biotechnology's Beneish M Score to see the likelihood of Apex Biotechnology's management manipulating its earnings.
Apex Biotechnology Stock Summary
Apex Biotechnology Corp. engages in the research, development, manufacture, and sale of medical devices by using biosensor technology worldwide. Apex Biotechnology Corp. was founded in 1997 and is headquartered in Hsinchu, Taiwan. APEX BIOTECHNOLOGY operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange.
You should never invest in Apex Biotechnology without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Apex Stock, because this is throwing your money away. Analyzing the key information contained in Apex Biotechnology's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Apex Biotechnology Key Financial Ratios
There are many critical financial ratios that Apex Biotechnology's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Apex Biotechnology Corp reports annually and quarterly.
Comparative valuation techniques use various fundamental indicators to help in determining Apex Biotechnology's current stock value. Our valuation model uses many indicators to compare Apex Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Apex Biotechnology competition to find correlations between indicators driving Apex Biotechnology's intrinsic value. More Info.
Apex Biotechnology Corp is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.34 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Apex Biotechnology Corp is roughly 2.95 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Apex Biotechnology's earnings, one of the primary drivers of an investment's value.
Apex Biotechnology Market Pulse
Quote
30.90
Change(%)
0.32
Change
0.10
Open
31.0
Low
30.55
High
31.05
Volume
0
Exchange
TW
Apex Biotechnology Thematic Clasifications
Apex Biotechnology Corp is part of Biotech investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services
This theme covers Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services. Get More Thematic Ideas
Apex Biotechnology February 2, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Apex Biotechnology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Apex Biotechnology Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Apex Biotechnology Corp based on widely used predictive technical indicators. In general, we focus on analyzing Apex Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Apex Biotechnology's daily price indicators and compare them against related drivers.
When running Apex Biotechnology's price analysis, check to measure Apex Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apex Biotechnology is operating at the current time. Most of Apex Biotechnology's value examination focuses on studying past and present price action to predict the probability of Apex Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apex Biotechnology's price. Additionally, you may evaluate how the addition of Apex Biotechnology to your portfolios can decrease your overall portfolio volatility.